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STATE-OF-THE-ART PAPER STATE-OF-THE-ART PAPER1209Patient Selection for Ventricular Assist DevicesLeslie W. Miller, Maya Guglin
The number of patients with advanced heart failure unresponsive to conventional medical
therapy is increasing rapidly. One of the most promising new alternatives to heart
transplantation is the use of ventricular assist devices (VADs). Currently there are no
nationally recognized guidelines for appropriate patient selection for these devices. This article
by Miller and Guglin reviews the current clinical indications and contraindications for VAD
therapy. As the survival rates post-procedure improve and the devices become smaller and
more durable, there likely will be a significant increase in patients who might benefit from
LVAD implantation.CLINICAL RESEARCH INTERVENTIONAL CARDIOLOGY1222Changes in the Types of Patients Undergoing PCI Over the Last 20 YearsMarieke L. Fokkema, Stefan K. James, Per Albertsson, Axel Akerblom, Fredrik Calais, Peter Eriksson,
Jens Jensen, Tage Nilsson, Bart J. de Smet, Iwar Sjögren, Björn Thorvinger, Bo Lagerqvist
Fokkema and colleagues describe the characteristics and outcomes of all patients treated with
PCI in Sweden over the last 2 decades. All patients undergoing a PCI procedure for the first
time between 1990 and 2010 from the SCAAR (Swedish Coronary Angiography and
Angioplasty Registry) were included. The mean age increased from 60 to 67 during this
period. The proportion of patients presenting with unstable coronary artery disease and
STEMI increased from 27% and 6.2% to 48% and 32% respectively. The 1-year mortality
increased from 2.2% in 1990 to 1995 to 5.9% in 2009 to 2010, but after adjustment for age
and indication a modest decrease was shown, mainly in STEMI patients.(continued on page A-20)
MARCH 26, 2013 (continued) A-20CARDIOVASCULAR RISK1231Progression of Coronary Calcium Predicts Risk of Coronary Heart Disease EventsMatthew J. Budoff, Rebekah Young, Victor A. Lopez, Richard A. Kronmal, Khurram Nasir,
Roger S. Blumenthal, Robert C. Detrano, Diane E. Bild, Alan D. Guerci, Kiang Liu, Steven Shea,
Moyses Szklo, Wendy Post, Joao Lima, Alain Bertoni, Nathan D. Wong
Coronary artery calcium (CAC) predicts future coronary heart disease (CHD), but there is
less evidence that serial measurements of CAC can be used to further refine risk. This report
from the Multi-Ethnic Study of Atherosclerosis included almost 6,000 persons who had
baseline and follow-up CAC scans approximately 2.5 years apart. Of those with baseline
CAC  0, 84% were still 0 at the follow-up scan; for those with CAC 0, 85% showed
progression. There was a graded relationship between CAC progression and CHD event risk,
with greater progression associated with greater risk. Further studies are needed to know if
interventions that retard the progression of CAC also reduce CHD risk.CARDIOVASCULAR RISK1240Levels of Cardiac Troponin I Predict Outcomes in Patients With Stable CADTorbjørn Omland, Marc A. Pfeffer, Scott D. Solomon, James A. de Lemos, Helge Røsjø, Ju¯rate˙ Šaltyte˙ Benth,
Aldo Maggioni, Michael J. Domanski, Jean L. Rouleau, Marc S. Sabatine, Eugene Braunwald, for the
PEACE Investigators
Omland and colleagues sought to determine the prognostic value of troponin I levels,
measured with a new high sensitivity assay (hs-TnI), for subjects with stable coronary artery
disease (CAD) and preserved systolic function. 98.5% of patients had hs-TnI concentrations
above the detection level (1.2 pg/ml). hs-TnI correlated moderately with hs-TnT and
N-terminal pro B-type natriuretic peptide (NT-proBNP). During a median follow-up of 5.2
years, subjects in the highest quartile of hs-TnI levels were at 4 times the risk of
cardiovascular death or heart failure compared to those in the 3 lower quartiles. In patients
with stable CAD and preserved LV systolic function, hs-TnI concentrations provide
incremental prognostic information to conventional risk markers and other cardiovascular
biomarkers, including hs-TnT.(continued on page A-21)
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1250Simulation Suggests Statins Are Cost-Effective for
Primary Prevention in Patients With Chronic Kidney DiseaseKevin F. Erickson, Sohan Japa, Douglas K. Owens, Glenn M. Chertow, Alan M. Garber,
Jeremy D. Goldhaber-Fiebert
Erickson and colleagues developed a decision-analytic model of chronic kidney disease (CKD)
and cardiovascular disease (CVD) to determine the cost-effectiveness of generic statins for
primary prevention in men and women with hypertension and mild-to-moderate CKD. For
65 year-old men with moderate hypertension and mild-to-moderate CKD, statins reduced
the combined rate of MI and stroke, yielded 0.10 quality-adjusted life years (QALYs), and
increased costs by $1,800 ($18,000 per QALY gained). For 65 year-old women, statins
yielded 0.06 QALYs and increased costs by $1,900 ($33,400 per QALY gained). Results
were sensitive to rates of rhabdomyolysis and drug costs. While statins reduce absolute CVD
risk in patients with CKD, increased risk of rhabdomyolysis, and competing risks associated
with progressive CKD, such as living long enough to require dialysis, partly offset these gains.CARDIOVASCULAR RISK1259Trends in Heart Failure-Associated Hospitalizations in the United StatesSaul Blecker, Margaret Paul, Glen Taksler, Gbenga Ogedegbe, Stuart Katz
In this nationally representative sample of hospitalizations in the United States, the total
number of heart failure (HF) related hospitalizations increased from 3.9 million in 2001 to
4.2 million in 2009. During this period, primary HF steadily decreased at an annual rate of
approximately 1%, while the number of hospitalizations with HF as a secondary diagnosis
increased by 1.6% annually, or nearly 400,000 annual admissions. As a result, the percentage
of hospitalizations with HF as a secondary diagnosis accounted for 75% of the total number
of HF-related hospitalizations in 2009. The authors speculate on the potential reasons for
these changes, but no clear cause is identified.
Editorial Comment: Veronique L. Roger, p. 1268(continued on page A-22)




1271Distal Luminal Attenuation May Help to Identify
Stenoses With CT Coronary AngiographyDennis T. L. Wong, Brian S. Ko, James D. Cameron, Nitesh Nerlekar, Michael C. H. Leung,
Yuvaraj Malaiapan, Marcus Crossett, Darryl P. Leong, Stephen G. Worthley, John Troupis, Ian T. Meredith,
Sujith K. Seneviratne
Recent studies suggest that contrast gradient attenuation along the arterial tree, or
transluminala ttenuation gradient (TAG), may be useful for determining the functional
significance of a coronary stenosis. Wong and partners compared the diagnostic accuracy of
TAG using 320-row computed tomography angiography (CTA) with invasively determine
fractional flow reserve (FFR). TAG in FFR-significant vessels was significantly lower than
TAG from FFR non-significant vessels. A TAG 320 cut-off of 15.1 HUs/10 mm
redicted FFR 0.8 with sensitivity of 77%, specificity 74%, positive predictive value 67%
nd negative predictive value 86% and improved the diagnostic accuracy for identifying
unctionally significant stenoses to CTA assessment alone.
ditorial Comment: Andrew J. Einstein, p. 1280CONGENITAL HEART DISEASE1283Living At Higher Altitude Adversely Affects Survival in Patients With A Fontan ProcedureJoy T. Johnson, Ian Lindsay, Ronald W. Day, Charlotte S. Van Dorn, James Hoffman, Melanie D. Everitt,
Anji T. Yetman
The success of the Fontan procedure depends in large part on low pulmonary vascular
resistance (PVR). Factors that increase PVR, such as living at high altitude, may adversely
affect long-term outcomes. Johnson and colleagues reviewed outcomes from a tertiary cardiac
care center in the Intermountain West (elevation 5,000 feet). There was no relationship
between type, age at, or era of Fontan procedure and long-term outcome. Correlates of long-
term, transplant-free survival included lower altitude at the primary residence. These results
imply that long-term outcomes following the Fontan procedure are adversely impacted by
higher residential altitude.YEAR IN CARDIOLOGY SERIES YEAR IN CARDIOLOGY SERIES1290The Year in Valvular Heart DiseaseShahbudin H. Rahimtoola
Rahimtoola reviews the most important articles regarding valvular heart disease published in
the last year, including commentaries that place the results in context.
